AFP — AFT Pharmaceuticals Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual income statement for AFT Pharmaceuticals, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	113	130	157	195	208
Cost of Revenue
Gross Profit	48.7	61.8	73	88.3	91.7
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	102	110	137	171	190
Operating Profit	10.7	20.4	19.7	24.2	17.6
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	7.89	18.7	15.8	22	16
Provision for Income Taxes
Net Income After Taxes	7.78	19.8	10.7	15.6	11.4
Minority Interest
Net Income Before Extraordinary Items
Net Income	7.78	19.8	10.7	15.6	12
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	7.59	19.8	10.7	15.6	12
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.074	0.19	0.102	0.149	0.114
Dividends per Share